Sporn J R
Division of Hematology-Oncology, University of Connecticut Health Center, Farmington.
Acta Haematol. 1991;85(4):209-11. doi: 10.1159/000204895.
A patient with de novo prolymphocytic leukemia who was refractory to chemotherapy and splenic radiation achieved a dramatic sustained response following 3 courses of therapy with fludarabine.
一名初发的原淋巴细胞白血病患者,对化疗和脾脏放疗均耐药,在接受3个疗程氟达拉滨治疗后获得了显著的持续缓解。